Moore, R.G. et al. 2026. A Novel Marker for the Management of Patients Diagnosed with Endometrial Adenocarcinoma of the Uterus: HE4 a novel serum marker for endometrial cancer. Clinical Journal of Obstetrics and Gynecology. 9, 1 (Mar. 2026), 1–7. DOI:https://doi.org/10.29328/journal.cjog.1001199.